Net Margin: Precision BioSciences, Inc. (DTIL)

DTIL (Precision BioSciences) - company brandmark

The net margin per ruble of revenue on this Precision BioSciences (DTIL) chart from the GURU.Markets service demonstrates market expectations, where the value of -87.50 reflects this status. This trend is driven by the bet on the ARCUS platform and an academic approach to R&D. The model is based on AI solutions without in-house production. Calibrated diagnostic systems and reserved capacities of contract manufacturing plants support stability.

precisionbiosciences.com (DTIL) Company Sales Margin: for the period 07/04/2022 - 11/19/2026

Summary analytical data breakdowns for Precision BioSciences, Inc. (DTIL)

- company stock exchange capitalization indicators:
Comprehensive company analysis:Precision BioSciences
Flagship merchandise of precisionbiosciences.com

Sales margins determine the share of net profit in total revenue, capturing the final efficiency of all trading operations. This metric distinguishes sustainable operating profit from short-term market anomalies. By analyzing actual net profit margins, an investor can observe expense trends and the business's pricing power. For Precision BioSciences (DTIL), this indicator reflects the implementation costs of ARCUS AI platforms. The automation of genome bioscreening should reduce costs, thereby stabilizing profitability.

Key competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX